img

TCT 2013.

The full coverage of TCT 2013, that takes place in San Francisco City from October 27th to November 1st .

Partnership Session: 
Optimizing PCI Outcomes: SOLACI in Partnership with TCT

  • Date: Monday, October 28 
  • 6:00 pm - 8:00 pm
  • Room: Moscone West, 3rd Floor, Room 3010

Moderators: Martin B. Leon, Jamil Abdalla Saad, Gregg W. Stone
Discussants: Jorge Gaspar, Jose L. Leiva-Pons, Jose Armando Mangione, Rogerio Sarmento-Leite

6:00 pm Selecting the Best Antiplatelet Strategy for ACS and Stable CAD (Oscar A. Mendiz)

6:10 pm Discussion

6:15 pm Making the Case for FFR/iFFR Use in >50% of Cases Before PCI  (Augusto D. Pichard)

6:25 pm Case Presentation: FFR/iFR Radically Changed How I Treated This Patient (Case Presenter: Pedro A. Lemos)

6:34 pm Discussion

6:39 pm Making the Case for IVUS Use in >50% of Cases During (Soo-Jin Kang)

6:49 pm Case Presentation: IVUS was Essential to This PCI (Case Presenter: Ricardo A. Costa)

6:58 pm Discussion

7:03 pm  How Should OCT Be Used in a Busy Cath Lab to Improve Clinical Outcomes (Pedro R. Moreno)

7:13 pm Case Presentation: OCT as Instrumental in Understanding This Case (Case Presenter: Akiko Maehara)

7:22 pm Discussion

7:27 pm Practical Suggestions for Imaging Modalities to Guide Bioresorbable Scaffold Deployment and Follow-Up Assessment (Robert-Jan van Geuns)

7:37 pm Case Presentation: Novel Imaging Insights After BVS Implantation Acute and Chronic (Case Presenter: Hector M. Garcia-Garcia)

7:46 pm Discussion

7:51 pm How Can I Adapt FFR/IVUS/OCT to LATAM Practice? (Rogerio Sarmento-Leite)

PDF

SAFE-PCI for Women: Radial versus femoral access for women
Radial access is associated with a lower rate of vascular and bleeding complications however female patients with smaller diameter arteries such access might be technically more difficult. ...

COREVALVE EXTREME RISK: Promising results with CoreValve in very high-risk patients
Percutaneous aortic valve implantation ( TAVI ) recently demonstrated its superiority over medical treatment in patients with severe aortic stenosis and high surgical risk . Furthermore ...

SORT OUT VI: Biolimus eluting stent versus zotarolimus-eluting stent; similar results
Few studies have compared head to head the 2nd generation drug eluting stents . This study randomized 1:1  3671 patients to receive a biolimus eluting stent with biodegradable polymer (1880 ...

HeartFlowNXT: Using noninvasive FFR shows promising results
The use of fractional flow reserve (FFR) is useful to determine the significance of coronary lesions . The ability to perform this physiologicalevaluation in a noninvasive base is an interesting ...

Exclusive Interview with Dr. Henrique Ribeiro on his article: coronary obstruction after TAVI
Recentemente uma revisão e metanálise sobre obstrução coronária após o implante de TAVI foi publicada na revista JAAC. Este artigo foi motivo de uma aula ...

LEVANT 2: Initial results from the new drug eluting balloon for femoropopliteal lesions
This prospective multicenter study randomized 476 patients 2:1 to paclitaxel eluting balloon versus conventional balloon for femoropopliteal region lesions with the primary objective of ...

RIBS V: Pharmacological balloon vs second-generation drug-eluting stent in the treatment of BMS restenosis
The ideal therapy for treating in-stent restenosis continues to be debated . The pharmacological balloons showed good results in this context, but no direct comparisons available of ...

SMART-CASE: Angiographic Guidanceangioplastyto >50% versus >70% lesions.
This prospective randomized study compared aggressive revascularization angiography injuries 50% versus a most conservative revascularization lesions>70%.The primary end point was death, ...

ADVISE II: iFFR comparable toFFRbut with out adenosine
Several studies tested the utility of fractional flow reserve ( FFR ) to assess coronary lesions functionally. The FFR required for its measurement amaximum hyperemia that usually, is ...

CHILL-MI: Hypothermia fails to show benefit in patients with acute ST- elevation IAM.
Hypothermia improves myocardial ischemia in animals but studies in humans failed to demonstrate benefit to that extent.We admitted 120 patients experiencing anterior-posterior STEMI with up to 6 ...

EUROMAX: Early and prolonged infusion of bivalirudin reduces mortality in AMI
Bivalirudin reduced mortality and bleeding compared to heparin and glycoprotein IIbIIIa in HORIZONS- AMI study. However there was a higher rate of acute stent thrombosis in patients receiving ...

NORDIC-BALTIC IV: 2 stents versus provisional stent in bifurcations
This study aimed to compare the strategy of 2 stents versus provisional stenting in true bifurcations .It was a multicenter, randomized trial included 221 patients in the provisional group and ...

TRYTON: Stent dedicated to bifurcations fails to demonstrate non-inferiority when compared with provisional
The aim of this study was to compare the results of stent TRYTON (non-drug eluting) in the side branch associated with the implantation of a drug-eluting stent in the main branch compared to the ...

TRANSLATE-POPS: Routine measurement of platelet aggregation generates a minimal impact on the treatment setting
The high platelet reactivity is associated with adverse events after stent implantation. Current guidelines consider the measurement of aggregability as a class IIB and there is no information ...

MOZART: IVUS reduces contrast volume needed for angioplasty
Contrast nephropathy is associated with increased morbidity and so this study evaluates the possibility of reducing the required necessary volume of contrast  using coronary intravascular ...

OPTIMIZE: 3 versus 12 months dual antiplatelet therapy after angioplasty with DES
Currently the recommendation is 12 months of dual antiplatelet after a drug-eluting stent angioplasty . This study compared the 3 - months versus 12 months of dual antiplatelet  after ...

DUTCH PEERS: Everolimus DES versus zotarolimus DES
This study randomized 1:1,  906 patients to receive zotarolimus-eluting stent and 905 patients to receive everolimus-eluting stent . The clinical and angiographic characteristics of both ...

FREEDOM: Insulin dependent versus non-insulin dependent with multivessel disease
From the total of 1900 patients in the FREEDOM study , 1248 did not require insulin (631 received angioplasty and 617 received CABG ) and 602 if required (325 received angioplasty and 277 ...

HYBRID: Hybrid revascularization in patients with multi-vessel
We included 200 patients (100 with hybrid revascularization and 100 with conventional surgery). The complete revascularization rate was similar between both groups (70%). Also, the event-free ...

GIANT: Evaluation of the genetic profile of CYP2C19 in patients undergoing primary angioplasty
The aim of this study was to evaluate the clinical impact resistance thienopyridines through genetic analysis of CYP2C19 receptor. The primary endpoint was  a combination of mortality, ...

TATORT-NSTEMI: Routinely thromboaspiration in patients with non ST-elevation AMI
Thromboaspiration in patients with ST-elevation is being questioned while in patients without elevation this strategy has not been studied. The study included 440 patients with non ST-elevation ...

REPRISE II: LOTUS valve for percutaneous aortic valve replacement
The aim of this study was to evaluate the safety and efficacy of the new device in patients with severe aortic stenosis at high surgical risk . We included 120 patients with a mean age of 84 years ...

ARCTIC-INTERRUPTION: 1 years versus 2 years of double anti-platelet
This study randomized 1259 patients to receive one year versus 2 years of double anti anti-platelet after implantation of a drug-eluting stent . The primary end point was a composite of death, ...

Top